Supervisory board
The Prosensa Supervisory board :
-
Daan Ellens - Chairman of the Supervisory board
Daan Ellens is chairman of the Prosensa supervisory board. He also serves as chairman of the supervisory board of Hybrigenics (F), Zealand Pharma (DK) and Kreatech Biotechnology (NL).
-
Stephen Bunting - Board member
Stephen Bunting is the Managing Partner of Abingworth LLP and has over 25 years experience in the venture capital business.
-
Rémi Droller - Board member
Rémi Droller holds a postgraduate degree in Molecular Biology from Paris VI University and a Masters degree in Management and Science from INA-PG/Reims Management School.
-
Peter Goodfellow - Board member
Peter Goodfellow joined the supervisory board in 2008. In addition, he serves as a director of the Institute of Cancer Research and as a member of several advisory boards.
-
Martijn Kleijwegt - Board member
Martijn Kleijwegt became a member Prosensa’s supervisory board in 2008. He founded Life Sciences Partners in 1998 and has been managing partner of Life Sciences Partners since then.
-
Jim Van heusden - Board member
Jim Van heusden is partner venture capital at Gimv, focused on investments in Life Sciences. He currently serves on the board of Ablynx, ActoGenix, Nereus Pharmaceuticals & Pronota.
-
John Shields - Board observer
John Shields has 13 years of operational experience in life science companies. He joined Abingworth in 2001 from Cantab Pharmaceuticals where he was Senior Vice-President, Research.
-
John de Koning - Board observer
John de Koning, Ph.D, joined LSP in 2006 and became partner in 2009. He currently serves on the supervisory boards of Pronota and Skyline Diagnostics.
